Delivra Health Brands (TSXV:DHB) Gross Margin %: 24.94% (As of Mar. 2026) — 26% Below Median


What is Delivra Health Brands Gross Margin %?

Delivra Health Brands TSXV:DHB Gross Margin % is 24.94% as of Mar. 2026, which is 26% below its 10-year median of 33.70. The stock has 3 warning signs investors should review. Among 936 Drug Manufacturers companies, Delivra Health Brands ranks worse than 55.34% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Delivra Health Brands's Gross Profit for the three months ended in Mar. 2026 was C$0.31 Mil. Delivra Health Brands's Revenue for the three months ended in Mar. 2026 was C$1.25 Mil. Therefore, Delivra Health Brands's Gross Margin % for the quarter that ended in Mar. 2026 was 24.94%.


The historical rank and industry rank for Delivra Health Brands's Gross Margin % or its related term are showing as below:

TSXV:DHB' s Gross Margin % Range Over the Past 10 Years
Min: -1414.47   Med: 33.7   Max: 127.27
Current: 45.51


During the past 13 years, the highest Gross Margin % of Delivra Health Brands was 127.27%. The lowest was -1414.47%. And the median was 33.70%.

TSXV:DHB's Gross Margin % is ranked worse than
55.34% of 936 companies
in the Drug Manufacturers industry
Industry Median: 48.5 vs TSXV:DHB: 45.51

Delivra Health Brands had a gross margin of 24.94% for the quarter that ended in Mar. 2026 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Delivra Health Brands was 37.70% per year.


Delivra Health Brands  (TSXV:DHB) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Delivra Health Brands had a gross margin of 24.94% for the quarter that ended in Mar. 2026 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Delivra Health Brands Gross Margin % Related Terms


Delivra Health Brands Gross Margin % Historical Data

* Premium members only.

The historical data trend for Delivra Health Brands's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delivra Health Brands Gross Margin % Chart

Delivra Health Brands Annual Data
Trend Dec16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.12 31.99 49.26 51.70 50.70

Delivra Health Brands Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.15 53.56 46.80 39.95 24.94

TSXV:DHB vs ZTS, UTHR: Gross Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delivra Health Brands Gross Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Delivra Health Brands's Gross Margin % falls into.



Delivra Health Brands Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Delivra Health Brands's Gross Margin for the fiscal year that ended in Jun. 2025 is calculated as

Gross Margin % (A: Jun. 2025 )=Gross Profit (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=6.8 / 13.37
=(Revenue - Cost of Goods Sold) / Revenue
=(13.37 - 6.592) / 13.37
=50.70 %

Delivra Health Brands's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=0.3 / 1.247
=(Revenue - Cost of Goods Sold) / Revenue
=(1.247 - 0.936) / 1.247
=24.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 24.94% mean?
Delivra Health Brands (TSXV:DHB) has a Gross Margin % of 24.94% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Delivra Health Brands and its competitors. This is 26% below median its historical median of 33.70. According to the industry distribution chart, Delivra Health Brands ranks #518 out of 936 companies in the Drug Manufacturers industry, placing it in the top 55.3%.
Is Delivra Health Brands' Gross Margin % too high?
Delivra Health Brands' current Gross Margin % of 24.94% is 26% below median its 10-year median of 33.70. The Drug Manufacturers industry median Gross Margin % is 48.50. Delivra Health Brands' value of 24.94% is 48.6% below this industry median. Based on the distribution chart, Delivra Health Brands ranks #518 out of 936 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Delivra Health Brands' Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #518 out of 936 companies for Gross Margin %. This places Delivra Health Brands in the lower half of its industry. The industry median Gross Margin % is 48.50. Delivra Health Brands' value of 24.94% is 48.6% below this benchmark. While the company's 10-year median is 33.70 vs. the industry median of 48.50, Delivra Health Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.50, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delivra Health Brands's current Gross Margin % of 24.94% is 48.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Delivra Health Brands and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current Gross Margin % is 24.94%, which is 26% below median its own 10-year median of 33.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (TSXV:DHB) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.25, compared to a current price of C$0.10 — trading 60% below its estimated fair value. The current Gross Margin % is 24.94%, which is 26% below median its 10-year median of 33.70 and 48.6% below the Drug Manufacturers industry median of 48.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Delivra Health Brands (TSXV:DHB), the current Gross Margin % is 24.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delivra Health Brands Business Description

Other Exchanges DHBUF:USA3F0:Germany
Address 999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.